Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 13Breast Neoplasms 5Prostatic Neoplasms 4Ovarian Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Neoplasms 3Neoplasm Metastasis 3Stomatitis 2Stomach Neoplasms 2Leukemia, Myeloid, Acute 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Trauma, Nervous System 1Thromboembolism 1Small Cell Lung Carcinoma 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma 1Lipoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Intracranial Hemorrhages 1

Interventions

isoquercitrin 1Tinzaparin 1Saline Solution 1Nadroparin 1Lenalidomide 1Enoxaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Thromboembolism × Saline Solution × Clear all
NCT00951574 2012-02-01

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

Italfarmaco

Phase 3 Completed
1,166 enrolled

Neoplasm Metastasis, Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡